Secondary |
Product Used For Unknown Indication |
31.1% |
Drug Use For Unknown Indication |
11.5% |
Multiple Myeloma |
9.8% |
Anticoagulant Therapy |
6.6% |
Thrombosis Prophylaxis |
6.6% |
Atrial Fibrillation |
3.3% |
Blood Pressure Abnormal |
3.3% |
Coagulopathy |
3.3% |
Deep Vein Thrombosis |
3.3% |
Hypertension |
3.3% |
Pain |
3.3% |
Peripheral Ischaemia |
3.3% |
Blood Triglycerides Increased |
1.6% |
Depression |
1.6% |
Diabetes Mellitus |
1.6% |
Ischaemic Heart Disease Prophylaxis |
1.6% |
Prophylaxis |
1.6% |
Pulmonary Arterial Hypertension |
1.6% |
Renal Cancer |
1.6% |
|
Thrombocytopenia |
20.0% |
Haemarthrosis |
10.0% |
Loss Of Consciousness |
10.0% |
Tooth Extraction |
10.0% |
Bleeding Time Prolonged |
5.0% |
Cronkhite-canada Syndrome |
5.0% |
Dyspnoea |
5.0% |
International Normalised Ratio Fluctuation |
5.0% |
Muscle Necrosis |
5.0% |
Rectal Haemorrhage |
5.0% |
Sepsis |
5.0% |
Subdural Haematoma |
5.0% |
Urinary Tract Infection |
5.0% |
Vascular Pseudoaneurysm |
5.0% |
|
Concomitant |
Product Used For Unknown Indication |
25.1% |
Drug Use For Unknown Indication |
20.2% |
Multiple Myeloma |
8.4% |
Anticoagulant Therapy |
6.7% |
Thrombosis Prophylaxis |
4.5% |
Cardiac Disorder |
4.1% |
Colitis Ulcerative |
4.1% |
Pulmonary Embolism |
3.9% |
Affective Disorder |
3.0% |
Fibromyalgia |
2.6% |
Rheumatoid Arthritis |
2.6% |
Antiplatelet Therapy |
1.9% |
Depression |
1.9% |
Thrombolysis |
1.9% |
Convulsion |
1.7% |
Hypertension |
1.7% |
Type 2 Diabetes Mellitus |
1.7% |
Psoriatic Arthropathy |
1.5% |
Contraception |
1.3% |
Diabetes Mellitus |
1.3% |
|
Thrombocytopenia |
14.3% |
Death |
12.9% |
Renal Failure Acute |
8.6% |
Vomiting |
8.6% |
Pneumonia Pneumococcal |
4.3% |
Renal Haematoma |
4.3% |
Syncope |
4.3% |
Ventricular Failure |
4.3% |
Weight Decreased |
4.3% |
Weight Increased |
4.3% |
Wheezing |
4.3% |
Anaemia |
2.9% |
Cerebral Haemorrhage |
2.9% |
Deep Vein Thrombosis |
2.9% |
Hypotension |
2.9% |
Infarction |
2.9% |
Loss Of Libido |
2.9% |
Multi-organ Failure |
2.9% |
Oedema |
2.9% |
Pain |
2.9% |
|
Interacting |
Drug Use For Unknown Indication |
55.6% |
Diverticulum |
22.2% |
Anticoagulant Therapy |
11.1% |
Antifungal Prophylaxis |
11.1% |
|
International Normalised Ratio Increased |
100.0% |
|